FFCP PHASE1:Mm9::chr17:35164593..35164602,-: Difference between revisions
From FANTOM5_SSTAR
m (moved FFCP PHASE1 mm9::chr17:35164593..35164602,- to FFCP PHASE1:Mm9::chr17:35164593..35164602,-: NSchange) |
No edit summary |
||
(7 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
| | |DHSsupport=NA | ||
| | |DPIdataset=NA | ||
|EntrezGene=78376 | |EntrezGene=78376 | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=29 | |||
|TSSclassifier=NA | |||
|UniProt= | |UniProt= | ||
|association_with_transcript=1bp_to_ENSMUST00000173211_5end | |||
|cluster_id=chr17:35164593..35164602,- | |||
|description=CAGE_peak_6_at_Ng23_5end | |||
|id=chr17:35164593..35164602,- | |||
|ontology_enrichment_celltype=CL:0000815!1.83e-11!1;CL:0000792!1.83e-11!1 | |||
|ontology_enrichment_celltype_v019_2=CL:0000815,3.07e-86,1;CL:0000792,3.07e-86,1;CL:0000624,2.93e-12,8;CL:0000791,4.56e-11,9;CL:0000789,4.56e-11,9;CL:0002420,4.56e-11,9;CL:0002419,4.56e-11,9;CL:0000790,4.56e-11,9;CL:0000084,2.51e-09,11;CL:0000827,2.51e-09,11;CL:0000838,1.13e-08,12;CL:0000542,4.08e-08,13;CL:0000051,4.08e-08,13 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002465!2.89e-30!3;UBERON:0001962!6.43e-21!2;UBERON:0001961!6.43e-21!2;UBERON:0001744!6.43e-21!2;UBERON:0003199!2.31e-11!1;UBERON:0000029!4.58e-11!1;UBERON:0001097!4.58e-11!1;UBERON:0003968!4.58e-11!1;UBERON:0008785!4.58e-11!1;UBERON:0001467!4.58e-11!1;UBERON:0001421!4.58e-11!1 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,4.9066862907799,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.47997726838022,0.68822784320151,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.338844532069132,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0.258937883647172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202860121388503,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.178065603667255,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,4.9066862907799,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.47997726838022,0.68822784320151,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.338844532069132,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0.258937883647172,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202860121388503,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.178065603667255,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p6@Ng23 | |||
}} | }} |
Latest revision as of 09:12, 26 September 2015
Short description: | p6@Ng23 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_6_at_Ng23_5end |
Coexpression cluster: | MCL_coexpression_mm9:29 |
Association with transcript: | 1bp_to_ENSMUST00000173211_5end |
EntrezGene: | Ng23 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
regulatory T cell | 3.07e-86 | 1 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell | 3.07e-86 | 1 |
CD4-positive, alpha-beta T cell | 2.93e-12 | 8 |
mature alpha-beta T cell | 4.56e-11 | 9 |
alpha-beta T cell | 4.56e-11 | 9 |
immature T cell | 4.56e-11 | 9 |
mature T cell | 4.56e-11 | 9 |
immature alpha-beta T cell | 4.56e-11 | 9 |
T cell | 2.51e-09 | 11 |
pro-T cell | 2.51e-09 | 11 |
lymphoid lineage restricted progenitor cell | 1.13e-08 | 12 |
lymphocyte | 4.08e-08 | 13 |
common lymphoid progenitor | 4.08e-08 | 13 |